Skip to content
Publish & Distribute
Publishing Solutions
Distribution Solutions
Library Services
Subjects
Architecture and Design
Arts
Business and Economics
Chemistry
Classical and Ancient Near Eastern Studies
Computer Sciences
Cultural Studies
Engineering
General Interest
Geosciences
History
Industrial Chemistry
Jewish Studies
Law
Library and Information Science, Book Studies
Life Sciences
Linguistics and Semiotics
Literary Studies
Materials Sciences
Mathematics
Medicine
Music
Pharmacy
Philosophy
Physics
Social Sciences
Sports and Recreation
Theology and Religion
Publications
Journals
Books
Proceedings
Publishers
Journal Matcher
Blog
Contact
Search
English
English
Deutsch
Polski
Español
Français
Italiano
Cart
Home
Journals
Immunohematology
Volume 21 (2005): Issue 4 (December 2005)
Requires Authorization
Reactivity of FDA-approved anti-D reagents with partial D red blood cells
W.J. Judd
W.J. Judd
Department of Pathology, University of Michigan
Ann Arbor, MI, United States
Search for this author on
Sciendo
|
Google Scholar
Judd, W.J.
,
M. Moulds
M. Moulds
Immunohematology Reference Laboratory ImmucorGamma
Houston, TX, United States
Search for this author on
Sciendo
|
Google Scholar
Moulds, M.
and
G. Schlanser
G. Schlanser
Immunohematology Reference Laboratory ImmucorGamma
Houston, TX, United States
Search for this author on
Sciendo
|
Google Scholar
Schlanser, G.
May 01, 2020
Immunohematology
Volume 21 (2005): Issue 4 (December 2005)
About this article
Previous Article
Next Article
Abstract
References
Authors
Articles in this Issue
Preview
PDF
Cite
Share
Download Cover
Published Online:
May 01, 2020
Page range:
146 - 148
DOI:
https://doi.org/10.21307/immunohematology-2019-409
Keywords
anti-D reagents
,
partial D red blood cells
,
gel column technology
© 2005 W.J. Judd, et al., published by Sciendo
